Eldred; Colin David
Patent Applications and Registrations
Patent applications and USPTO patent grants for Eldred; Colin David.The latest application filed is for "compounds".
- Eldred; Colin David - Stevenage GB
- Eldred; Colin David - Hertfordshire GB
- Eldred; Colin David - Hertford GB
- Eldred; Colin David - Herts GB
| Patent | Date |
|---|---|
| Compounds Grant 8,329,730 - Heightman , et al. December 11, 2 | 2012-12-11 |
| Indazoles as glucocorticoid receptor ligands Grant 8,093,281 - Eldred , et al. January 10, 2 | 2012-01-10 |
| Compounds App 20110039889 - Eldred; Colin David ; et al. | 2011-02-17 |
| Substituted Piperazines, (1,4) Diazepines, And 2,5-diazabicyclo (2.2.1) Heptanes As Histamine H1 And/or H3 Antagonists Or Histamine H3 Reverse Antagonists App 20100075953 - Ancliff; Rachael ; et al. | 2010-03-25 |
| Quinoline Derivatives As Phosphodiesterase Inhibitors App 20090312325 - Baldwin; Ian Robert ; et al. | 2009-12-17 |
| Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases Grant 7,622,464 - Ancliff , et al. November 24, 2 | 2009-11-24 |
| 1,7-Naphthyridines App 20090270444 - Eldred; Colin David ; et al. | 2009-10-29 |
| Quinoline derivatives as phosphodiesterase inhibitors Grant 7,566,786 - Baldwin , et al. July 28, 2 | 2009-07-28 |
| Indazoles As Glucocorticoid Receptor Ligands App 20090074675 - Eldred; Colin David ; et al. | 2009-03-19 |
| 1,7-Naphthyridines as Pde4 Inhibitors App 20080146563 - Eldred; Colin David ; et al. | 2008-06-19 |
| 4-Aminoquinoline-3-Carboxamide Derivatives as Pde4 Inhibitors App 20080096884 - Edlin; Christopher D. ; et al. | 2008-04-24 |
| Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation App 20070191426 - Edlin; Christopher ; et al. | 2007-08-16 |
| Quinoline derivatives as phosphodiesterase inhibitors App 20070142373 - Baldwin; Ian Robert ; et al. | 2007-06-21 |
| Compounds useful in the treatment of inflammatory diseases Grant 7,157,457 - Ancliff , et al. January 2, 2 | 2007-01-02 |
| Morpholin-acetamide derivatives for the treatment of inflammatory diseases Grant 7,101,882 - Ancliff , et al. September 5, 2 | 2006-09-05 |
| Morpholin-acetamide derivatives for the treatment of inflammatory diseases App 20060079525 - Ancliff; Rachael Anne ; et al. | 2006-04-13 |
| Novel compounds App 20060063765 - Ancliff; Rachael Ann ; et al. | 2006-03-23 |
| N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions App 20060058299 - Ancliff; Rachael Ann ; et al. | 2006-03-16 |
| Compounds App 20060019964 - Ancliff; Ranchael Ann ; et al. | 2006-01-26 |
| Chemical compounds Grant 6,740,644 - Eldred , et al. May 25, 2 | 2004-05-25 |
| Morpholin-acetamide derivatives for the treatment of inflammatory diseases App 20040058923 - Ancliff, Rachael Anne ; et al. | 2004-03-25 |
| Compounds useful in the treatment of inflammatory diseases App 20040058907 - Ancliff, Rachael Anne ; et al. | 2004-03-25 |
| Adenosine derivatives and methods of administration Grant 6,677,316 - Bays , et al. January 13, 2 | 2004-01-13 |
| Chemical compounds App 20030158146 - Eldred, Colin David ; et al. | 2003-08-21 |
| Adenosine derivatives App 20030096788 - Bays, David Edmund ; et al. | 2003-05-22 |
| Chemical compounds Grant 6,544,960 - Eldred , et al. April 8, 2 | 2003-04-08 |
| Adenosine derivatives Grant 5,998,388 - Ellis , et al. December 7, 1 | 1999-12-07 |
| Piperidineacetic acid derivatives useful as fibrinogen antagonist agent Grant 5,861,414 - Allen , et al. January 19, 1 | 1999-01-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 